Introducing the SARS-CoV-2 External Control Kit

Since the global outbreak of the novel coronavirus, adapting to rapid changes in the state of the COVID-19 pandemic has presented an enormous challenge for clinical laboratories ready to respond with molecular diagnostic testing. Poised to make some of the greatest contributions to human health, labs need to ensure precision and accuracy while emergent understanding shifts viral targets, and unstable infection rates impact available resources.

When change is constant and there’s less time for progress and less room for error, you need to minimize variability. With ongoing mutations, limited workforces, and supply chain challenges, where can you gain a level of control?

That’s why ATCC has created a full-process quality control for SARS-CoV-2 that gives labs the confidence of stability and dependability amid the rapidly changing COVID-19 testing landscape. This ready-to-run kit equips clinical labs with the validated universal controls needed to easily verify and assess the performance their testing workflow, regardless of which molecular diagnostic assay is being used.

ATCC SARS-CoV-2 External Control Kit – A platform agnostic, full-process control designed to give you more confidence in your results.

Gain control amid chaos

Even when targets and demands are unpredictable, the right external controls help bring stability to seeming disarray.

Order here

Bringing Value to Your Quality Control

ATCC’s ready-to-use SARS-CoV-2 External Control kit requires no further dilutions, which allows for optimal workflow implementation, increased lab efficiency, and better consistency in clinical labs performing SARS-CoV-2 diagonstic tests

The kit's SARS-CoV-2 reference material utilizes heat-inactivated virus to ensure safe handling in BSL-1 environments

Native SARS-CoV-2 Washington state strain (2019-nCoV/USA-WA1/2020) is closer to the clinical sample than synthetic controls and provides an additional layer of assurance that your test is detecting the target of interest

Whole-genome sequenced virus allows for universal use across multiple platforms utilized for COVID-19 diagnostic testing in clinical labs

Full-process control allows for a single control to assess the performance of critical workflow steps, and it is ideal for integrated solutions that combine RNA extraction and amplification in a single platform

The design, format, and validation of ATCC's SARS-CoV-2 External Control Kit brings stability to the shifting environment of COVID-19 diagnostic testing. With diagnostic assay quality control measures, reference materials, and standards that combine decades of expertise and processes designed for the challenge at hand, our frontline efforts to combat COVID-19 will help you gain a measure of stability when you need it most.

As a trusted source for biological standards during decades of epidemics, ATCC is committed to global health and humanity. With our deep history in providing credible materials and developing solutions, we know what it takes to step up to the challenges and meet your needs today.


Not for in vitro diagnostic use. Research use only.